Insulet Corporation - Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor

Omnipod 5 is the world’s first tubeless automated insulin delivery system to achieve CE mark approval with multiple continuous glucose monitoring (CGM) sensor brands. Latest Omnipod 5 integration is expected to be available in the United Kingdom and Netherlands in the first half of 2024, with additional markets to follow. Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced it has

Diabetes Tech Highlights: JP Morgan Healthcare Conference 2024

Buy Insulet

Libre Life Diabetes News February 2024, by Samantha, Love My Libre, Feb, 2024

Eric Benjamin on LinkedIn: Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott…

CE Mark approval of Omnipod 5 integration with Abbott FreeStyle Libre 2 plus sensor - Insulet - Medical Update Online

Dr. Trang Ly on LinkedIn: #insulet #omnipod5 #omnipod

Insulet's (PODD) Omnipod 5 Gets CE Mark for Added Compatibility

The Savvy Diabetic

ETFs Holding PODD, Insulet Corp

Libre Life Diabetes News February 2024, by Samantha, Love My Libre, Feb, 2024

FreeStyle Libre 2

Getting started with FreeStyle Libre 2

Freestyle Libre 2 CGM, Strategy and Strength

FreeStyle Libre 2 Approved for Use in U.S.

Abbott's Freestyle Libre glucose monitoring system, USA